Updated Jul 16, 2026
Kaplan Andrew T. has filed 1 SEC Form 4 filing across 1 company in the last 90 days — buying. Lifetime open-market purchases: $134.38M.
Andrew T. Kaplan is associated with Kailera Therapeutics, Inc., as indicated by recent SEC filings. Specific details about his role and contributions to the company are not widely documented.
| Role | Insider |
|---|---|
| Notability | 10/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-04-20 | KLRA | Kailera Therapeutics, Inc. | P — Open-market purchase | 8.40M | $16.00 | $134.38M |
| 2026-04-20 | KLRA | Kailera Therapeutics, Inc. | J — Other acquisition / disposition | 17.86M | — |
Andrew T. Kaplan is associated with Kailera Therapeutics, Inc., as indicated by recent SEC filings. Specific details about his role and contributions to the company are not widely documented.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 1 open-market purchases ($134.38M) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Kaplan Andrew T. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.